Recent News

By Category: Bioterrorism

Sarepta’s bioterrorism drug found safe in humans

(Boston Business Journal) While most attention on Sarepta Therapeutics has concerned its drugs for Duchenne’s muscular dystrophy, today the Cambridge biotech reported data from an early-stage trial of its potential drug for the bio-terrorism infection known as the Marburg virus. Marburg is a deadly infection disease first recognized in 1967 and endemic to Africa. Its Read More »

February 12, 2014
| Filed under North America, Bioterrorism, Countermeasures, and Research
Share

EPA Study on Bioterrorism Decontamination Techniques

(Global Biodefense) The U.S. Environmental Protection Agency (EPA), along with federal partners, this week announced the results of a multi-year project called Bio-Response Operational Testing and Evaluation (BOTE) that tested and evaluated decontamination techniques for a biological incident.

February 12, 2014
| Filed under North America, Biosafety, Bioterrorism, and Research
Share

House Approves Bill on WMD Medical Countermeasures Expenditures

(Global Security Newswire-NTI) The U.S. House on Monday passed a bill that would authorize the use of certain federal grants for improving medical responses to a chemical or biological strike. “Experts have repeatedly noted that the threat of a WMD attack is real,” said Representative Gus Bilirakis (R-Fla.), the bill sponsor, in released comments.”

February 11, 2014
| Filed under Bioterrorism, Countermeasures, and Policy & Initiatives
Share

Jury finds two men guilty in ricin plot

(The Marietta Daily Journal) A jury found two Georgia men guilty on Friday of plotting to make the poison ricin in what prosecutors described as a plan to target federal government officials. The jury deliberated for 90 minutes before finding Ray Adams, 57, and Samuel Crump, 71, guilty on two counts against them. The verdict Read More »

February 10, 2014
| Filed under North America, Agents & Toxins, and Bioterrorism
Share

Drug for Bioterrorism Antimicrobial Resistant Infections Funded by HHS

(Homeland Security Today) A new drug that is expected to help protect the public against two bioterrorism threats will advance in development under a public-private partnership, the Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) announced. HHS said the new drug will also provide “a new Read More »